Rabbat et al used criteria to determine whether or not to admit a patient with acute myeloid leukemia (AML) to the intensive care unit (ICU). This relates to the dismal prognosis for many patients facing progressive disease or multi-organ failure. The authors are from Hopital Hotel Dieu in Paris.